In-hospital Outcomes of Healthcare-associated COVID-19 (Omicron) Versus Healthcare-associated Influenza: A Retrospective, Nationwide Cohort Study in Switzerland
Clinical Infectious Diseases · 04.02.2026 · 81 (6) · e650-e658
DOI: 10.1093/cid/ciae558 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 13.11.2024. Verfasst von Rebecca Grant und 22 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control Program and WHO Collaborating Center, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Cross Infection. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Office of Public Health in Switzerland.
Abstract (Originalsprache)
Background
As coronavirus disease 2019 (COVID-19) is integrated into existing infectious disease control programs, it is important to understand the comparative clinical impact of COVID-19 and other respiratory diseases.
Methods
We conducted a retrospective cohort study of patients with symptomatic healthcare-associated COVID-19 or influenza reported to the nationwide, hospital-based surveillance system in Switzerland. Included patients were adults (aged ≥18 years) hospitalized for ≥3 days in tertiary care and large regional hospitals. Patients had COVID-19 symptoms and a real-time polymerase chain reaction–confirmed severe acute respiratory syndrome coronavirus 2 infection ≥3 days after hospital admission between 1 February 2022 and 30 April 2023, or influenza symptoms and a real-time polymerase chain reaction–confirmed influenza A or B infection ≥3 days after hospital admission between 1 November 2018 and 30 April 2023. Primary and secondary outcomes were 30-day in-hospital mortality and admission to intensive care unit, respectively. Cox regression (Fine-Gray model) was used to account for time dependency and competing events, with inverse probability weighting to adjust for confounding.
Results
We included 2901 patients with symptomatic, healthcare-associated COVID-19 (Omicron) and 868 patients with symptomatic, healthcare-associated influenza from 9 hospitals. We found a similar case fatality ratio between healthcare-associated COVID-19 (Omicron) (6.2%) and healthcare-associated influenza (6.1%) patients; after adjustment, patients had a comparable subdistribution hazard ratio for 30-day in-hospital mortality (0.91; 95% confidence interval, .67–1.24). A similar proportion of patients were admitted to the intensive care unit (2.4% COVID-19; 2.6% influenza).
Conclusions
COVID-19 and influenza continue to cause severe disease among hospitalized patients. Our results suggest that in-hospital mortality risk of healthcare-associated COVID-19 (Omicron) and healthcare-associated influenza are comparable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infection Control Program and WHO Collaborating Center, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
- Infection Antimicrobials Modeling Evolution U 1137, INSERM, Université Paris-Cité, Paris, France.
- MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, United Kingdom.
- Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
- Department of Infectious Diseases, Bern University Hospital (Inselspital), University of Bern, Bern, Switzerland.
- Swissnoso, the National Center for Infection Control, Bern, Switzerland.
ORCID-Profile: Rebecca Grant, Marlieke E A de Kraker, Holly Jackson, Mohamed Abbas, Rami Sommerstein, Nicolas Troillet, Peter W Schreiber, Philipp Jent, Sarah Tschudin-Sutter, Maria Süveges, Laura Urbini, Ursina Roder, Marie-Céline Zanella
Förderung
- Federal Office of Public Health in Switzerland
Zitieren
APA
Grant, R., de Kraker, M. E. A., Buetti, N., Jackson, H., Abbas, M., Sobel, J. A., Sommerstein, R., Eder, M., Balmelli, C., Troillet, N., Schreiber, P. W., Jent, P., Senn, L., Flury, D., Tschudin-Sutter, S., Buettcher, M., Süveges, M., Urbini, L., Keiser, O., …, & CH-SUR Study Group (2026). In-hospital Outcomes of Healthcare-associated COVID-19 (Omicron) Versus Healthcare-associated Influenza: A Retrospective, Nationwide Cohort Study in Switzerland. Clinical Infectious Diseases, 81(6), e650-e658. https://doi.org/10.1093/cid/ciae558
Vancouver
Grant R, de Kraker MEA, Buetti N, Jackson H, Abbas M, Sobel JA, et al. In-hospital Outcomes of Healthcare-associated COVID-19 (Omicron) Versus Healthcare-associated Influenza: A Retrospective, Nationwide Cohort Study in Switzerland. Clinical Infectious Diseases. 2026;81(6):e650-e658. doi:10.1093/cid/ciae558
BibTeX
@article{Grant2026,
author = {Grant, Rebecca and de Kraker, Marlieke E A and Buetti, Niccolò and Jackson, Holly and Abbas, Mohamed and Sobel, Jonathan Aryeh and Sommerstein, Rami and Eder, Marcus and Balmelli, Carlo and Troillet, Nicolas and Schreiber, Peter W and Jent, Philipp and Senn, Laurence and Flury, Domenica and Tschudin-Sutter, Sarah and Buettcher, Michael and Süveges, Maria and Urbini, Laura and Keiser, Olivia and Roder, Ursina and Harbarth, Stephan and Zanella, Marie-Céline and CH-SUR Study Group, CH-SUR Study Group},
title = {In-hospital Outcomes of Healthcare-associated COVID-19 (Omicron) Versus Healthcare-associated Influenza: A Retrospective, Nationwide Cohort Study in Switzerland},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {81},
number = {6},
pages = {e650--e658},
doi = {10.1093/cid/ciae558}
}
EUVIMED